RNAZ TRANSCODE THERAPEUTICS INC Delisting Actions 8-K Filing 2023 - Delisting Notice Transcode Therapeutics, Inc. received a letter from Nasdaq stating that its common stock did not meet the minimum bid price requirement for continued listing, but the company has been given a 180-day period to regain compliance.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC